Hims & Hers Shares Fall Ahead of Earnings

Hims & Hers Health stock dropped 10.31% to $23.32 on Monday as the company prepares to report third-quarter results after the market close.

Updated on Nov. 9, 2026 in Healthcare

Mid-rise glass office building at dusk with a bare concrete plaza in the foreground under long soft shadows and cool blue sky.
Shares of Hims & Hers Health fell 10.31% to $23.32 on Monday as the telehealth company prepared to report third-quarter results after the market close. AI Illustration. Upload story photo >

Live Poll

Would you consider investing in a telehealth company like Hims & Hers?

Shares of Hims & Hers Health fell 10.31% to $23.32 in Monday trading ahead of its scheduled third-quarter earnings release. The company is set to report after the market closes.

Why it matters

Second-quarter results gave investors a mixed picture, with sales beating forecasts while the loss per share came in well below expectations. The stock's decline ahead of the report reflects uncertainty over whether the company's growing subscriber base will translate into profit.

Hims & Hers raised its 2026 sales forecast to $3.1 billion to $3.3 billion, while Wall Street projects third-quarter revenue of $892.89 million and a 6-cent profit per share. The company has not yet reported whether those projections will be met.

The players

Hims & Hers Health

A telehealth company offering subscription-based health and wellness services, whose stock trades on the New York Stock Exchange.

The details

Hims & Hers Health shares were down 10.31% at $23.32 at the time of publication on Monday, November 9. Analysts expect the company to turn to positive earnings, but the second-quarter loss and the wide miss against expectations have kept investors cautious.

Timeline

  1. Second quarter 2026: Sales beat forecasts, earnings missed, and subscribers reached 2.9 million.

  2. 2026: Full-year sales forecast raised to $3.1 billion to $3.3 billion.

  3. Monday, November 9, 2026: Shares fell 10.31% ahead of earnings.

  4. Third quarter 2026: Earnings report scheduled after the market close.

Market Landscape

Hims & Hers's subscriber growth reflects the broader expansion of direct-to-consumer telehealth in the United States. Investors are now weighing whether that model can convert rising sales into sustained profitability.

Subscribers to Hims & Hers services are not directly affected by the share price drop, but the earnings report may signal whether the company's pricing and subscription offerings remain stable. Customers should watch for any changes to subscription tiers or service availability announced alongside the results.

The takeaway

Growth in subscribers does not guarantee profit, so investors and customers alike should watch whether revenue gains translate into earnings in the coming quarters. The third-quarter report will offer the first clear test of that balance.

What happens next

Hims & Hers Health is scheduled to release third-quarter earnings after the market close, with Wall Street projecting $892.89 million in revenue and a 6-cent profit per share.

Further reading

Explore more U.S. healthcare business coverage to see how telehealth companies like Hims & Hers fit into the wider industry.

Live Poll

Would you consider investing in a telehealth company like Hims & Hers?